5% STAKE4598.TTSECAYMAN ISLANDS

Evo Fund discloses 43.20% stake in Delta-Fly Pharma

Summary

Evo Fund and joint holders filed a New 5%+ stake (large shareholding report) via EDINET on 2026-08-17 11:15 JST concerning Delta-Fly Pharma, Inc. Reported holding ratio: 43.20%.

Open the price chart on TradingView.

Source: EDINET S100YX10 ↗ · PDL1.0 · Not investment advice